Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, SBS

PSTOX Lab Announces PSTOX Wealth Suite - Croesus to Salesforce Integration


MONTREAL, March 20, 2024 /CNW/ - PSTOX Lab, a fintech leader specializing in Salesforce solutions, today unveiled its PSTOX Wealth Suite, a new offering on the Salesforce AppExchange. This suite, designed to empower investment advisors, features PSTOX Wealth for large firms and PSTOX Wealth Light for small to medium-sized firms, providing comprehensive financial tools and data within Salesforce.

PSTOX Lab's mission is to enhance investment advisors' capabilities with seamless access to financial information and tools. The PSTOX Wealth Suite embodies this, offering a solution that integrates effortlessly with Salesforce. It enables advisors to access financial data, monitor performance, and make informed decisions efficiently.

PSTOX Wealth for Large Firms

PSTOX Wealth integrates Croesus into Salesforce, offering a comprehensive view of clients, accounts, financial transactions, portfolio details, asset allocation, and performance. This package supports advanced reporting, helping advisors generate insights and communicate effectively with clients. It's designed to streamline operations, enhance client engagement, and drive growth.

PSTOX Wealth Light for Small to Medium-Sized Firms

PSTOX Wealth Light provides essential client, xaccount, and financial data integration from Croesus, including a Performance Calculation module. Tailored for smaller firms, this package offers tools needed to compete effectively, ensuring scalability and efficiency.

Availability

Both PSTOX Wealth and PSTOX Wealth Light are now accessible on the Salesforce AppExchange, enhancing Salesforce experiences with specialized financial management tools. This launch demonstrates PSTOX Lab's commitment to innovation and its vision to transform wealth management through technology.

Philip Whitford, Partner at PSTOX Lab, expressed, "We're proud to introduce the PSTOX Wealth Suite to the Salesforce AppExchange. Our solutions are crafted to support investment advisors, regardless of firm size, providing the necessary data and tools to excel in today's competitive market."

For more details on the PSTOX Wealth Suite and its benefits for your firm, visit the Salesforce AppExchange website.

About PSTOX Lab

PSTOX Lab is a leading fintech firm dedicated to empowering investment advisors with innovative Salesforce solutions. By integrating sophisticated financial management capabilities and financial data, PSTOX Lab aims to boost advisors' productivity, client satisfaction, and industry growth.

 

SOURCE PSTOX Lab


These press releases may also interest you

at 18:05
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
Ibbaka Revenue Retention Maturity Model Helps B2B SaaS Companies Uncover Hidden Opportunities Within Customer Revenue Growth
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) Extends Initiative to SF Bay Area Families
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...

More news about Science and technology...


News published on and distributed by: